EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study

Jamy Ard, Lee M Kaplan, Scott Kahan, Rekha Kumar, Hong Kan iD, Julia P Dunn, Tracy J Sims, Nadia N Ahmad, Kristen King-Concialdi, Sheila Drakeley iD, Adam Jauregui, Kimberly Gudzune

Population Health Management · 2025-06 · 28 (3) · 150-160

DOI: 10.1089/pop.2024.0239 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Population Health Management, online erschienen am 04.06.2025. Verfasst von Jamy Ard und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity, Obesity Management. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Personal health factors and direct and indirect costs of obesity affect employers and employees. This research aimed to understand perceptions of obesity management and anti-obesity medications (AOMs) among employers and employees. In 2022, people with obesity and employers completed cross-sectional surveys about perceptions of obesity and its management, including AOMs. Data were analyzed with descriptive statistics. Data from 461 employed people with obesity (EwO) and 51 employer representatives (ER) were analyzed. Both EwO and ER acknowledged the impact of obesity on future health problems (88.3%; 100.0%) and perceived obesity as a disease (60.5%; 80.4%) to varied degrees. Both groups perceived an incremental value in combining self-directed lifestyle changes and AOMs (57.5%; 66.7%) and perceived healthcare provider-guided lifestyle change alongside AOMs as the most effective approach for maintaining long-term weight reduction (56.4%; 66.6%). More than two-thirds (68.6%) of ER expressed willingness to revisit their AOM coverage decisions, though cost of medication coverage (72.5%) and affordability of medications for employees (68.7%) were identified as barriers. ER believed that data showing reductions in premiums and claims at their organizations (78.4%) would be helpful in supporting the coverage of AOMs. While EwO and ER were receptive toward AOMs, organization-level barriers existed with AOM coverage. Evidence demonstrating the benefits of evidence-based obesity care, direct/indirect cost reductions, and the impact of obesity may address barriers to AOM coverage and improve obesity care and outcomes of their workforces.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsObesityObesity ManagementHumansMaleFemaleCross-Sectional StudiesUnited StatesMiddle AgedAdultSurveys and Questionnaires

Stichwörter der Autor:innen

anti-obesity medicationsbarriersemployersobesityoverweight

Substanzen

Anti-Obesity Agents

Autor:innen und Institutionen

  • Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Obesity, Metabolism, and Nutrition Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • George Washington University School of Medicine, Washington, District of Columbia, USA.
  • Weill Cornell Medical College, New York, New York, USA.
  • Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Oracle Life Sciences, Austin, Texas, USA.

ORCID-Profile: Hong Kan, Sheila Drakeley

Zitieren

APA

Ard, J., Kaplan, L. M., Kahan, S., Kumar, R., Kan, H., Dunn, J. P., Sims, T. J., Ahmad, N. N., King-Concialdi, K., Drakeley, S., Jauregui, A., & Gudzune, K. (2025). Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study. Population Health Management, 28(3), 150-160. https://doi.org/10.1089/pop.2024.0239

Vancouver

Ard J, Kaplan LM, Kahan S, Kumar R, Kan H, Dunn JP, et al. Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study. Population Health Management. 2025;28(3):150-160. doi:10.1089/pop.2024.0239

BibTeX
@article{Ard2025,
  author = {Ard, Jamy and Kaplan, Lee M and Kahan, Scott and Kumar, Rekha and Kan, Hong and Dunn, Julia P and Sims, Tracy J and Ahmad, Nadia N and King-Concialdi, Kristen and Drakeley, Sheila and Jauregui, Adam and Gudzune, Kimberly},
  title = {Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE Study},
  journal = {Population Health Management},
  year = {2025},
  volume = {28},
  number = {3},
  pages = {150--160},
  doi = {10.1089/pop.2024.0239}
}
Kostenlos starten →